AGM/EGMJun 5, 2026, 04:07 PM
Artelo Biosciences to Increase Authorized Common Stock to 500M
AI Summary
Artelo Biosciences, Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on July 17, 2026. Stockholders will vote on the election of three Class III director nominees and a proposal to amend the Articles of Incorporation to increase the authorized shares of common stock from 166,666,667 to 500,000,000. The Board of Directors recommends voting "FOR" all proposals.
Key Highlights
- 2026 Annual Meeting of Stockholders scheduled for July 17, 2026, at 8:00 a.m. Pacific Time, virtually.
- Proposal to elect three Class III director nominees: Gregory R. Reyes, Tamara A. Favorito, and Gregory D. Gorgas.
- Proposal to increase authorized common stock from 166,666,667 to 500,000,000 shares.
- Record date for voting is May 22, 2026, with 2,848,540 shares of common stock outstanding.
- A 1-for-3 reverse stock split was effective March 9, 2026.
- Board of Directors recommends a "FOR" vote on all proposals.
Price Impact
More from ARTL